Twinlab Consolidated Holdings, Inc. (TLCC)
- Previous Close
0.0108 - Open
0.0108 - Bid --
- Ask --
- Day's Range
0.0108 - 0.0108 - 52 Week Range
0.0050 - 0.1000 - Volume
222 - Avg. Volume
345 - Market Cap (intraday)
2.785M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Aug 12, 2024 - Aug 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, skincare, and sports nutrition products under the Twinlab, Reserveage, and ResVitale brands; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also provides services between private label distributors and contract manufacturers under the NutraScience Labs brand name. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, whole herbs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 1968 and is based in Boca Raton, Florida.
www.tchhome.com17
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TLCC
Performance Overview: TLCC
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TLCC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TLCC
Valuation Measures
Market Cap
2.79M
Enterprise Value
98.86M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.22
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-102.79%
Return on Assets (ttm)
-2.80%
Return on Equity (ttm)
--
Revenue (ttm)
12.65M
Net Income Avi to Common (ttm)
-9.55M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
139k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
11M
Research Analysis: TLCC
Company Insights: TLCC
TLCC does not have Company Insights